Aluminum Hydroxide and Magnesium Trisilicate and Obinutuzumab Intravenous
Determining the interaction of Aluminum Hydroxide and Magnesium Trisilicate and Obinutuzumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aluminum hydroxide / magnesium trisilicate
Brand name: Drysol, Hypercare, Xerac AC, Gaviscon Tablet
Synonyms: n.a.
Generic Name: obinutuzumab
Brand name: Gazyva
Synonyms: Obinutuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aluminum Hydroxide and Magnesium Trisilicate-Obizur
- Aluminum Hydroxide and Magnesium Trisilicate-Obizur Intravenous
- Aluminum Hydroxide and Magnesium Trisilicate-Obredon
- Aluminum Hydroxide and Magnesium Trisilicate-Ocaliva
- Aluminum Hydroxide and Magnesium Trisilicate-Occlucort
- Aluminum Hydroxide and Magnesium Trisilicate-Occlusal-HP Topical
- Obinutuzumab Intravenous-Aluminum hydroxide, magnesium hydroxide, and simethicone
- Obinutuzumab Intravenous-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Chewable Tablets
- Obinutuzumab Intravenous-Aluminum Hydroxide, Magnesium Hydroxide, and Simethicone Suspension
- Obinutuzumab Intravenous-Alunbrig
- Obinutuzumab Intravenous-Alupent
- Obinutuzumab Intravenous-Alupent (Metaproterenol Syrup)